2003
DOI: 10.1016/s0968-0896(03)00438-3
|View full text |Cite
|
Sign up to set email alerts
|

A novel structural class of potent inhibitors of NF-κB activation: structure–activity relationships and biological effects of 6-aminoquinazoline derivatives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
60
0
1

Year Published

2007
2007
2016
2016

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 66 publications
(64 citation statements)
references
References 17 publications
2
60
0
1
Order By: Relevance
“…7c), as expected if HSP70 limits pro-inflammatory signalling that is beneficial to the virus. We also tested the effect of QNZ, an inhibitor of NF-kB activation (Tobe et al, 2003) and found that, consistent with the effect of TNFa treatment, QNZ reduced Ad5 late gene expression in both cell types (Fig. 7d).…”
Section: Possible Roles Of Hsp70 During Ad5 Infectionsupporting
confidence: 63%
“…7c), as expected if HSP70 limits pro-inflammatory signalling that is beneficial to the virus. We also tested the effect of QNZ, an inhibitor of NF-kB activation (Tobe et al, 2003) and found that, consistent with the effect of TNFa treatment, QNZ reduced Ad5 late gene expression in both cell types (Fig. 7d).…”
Section: Possible Roles Of Hsp70 During Ad5 Infectionsupporting
confidence: 63%
“…2C). We also treated WT OCPs with a recently developed nonspecific NF-B inhibitor (31,36) and found that it also inhibited RANKL-induced VEGF-C expression in a dosedependent manner (Fig. 2D).…”
Section: Nf-b Regulates Rankl-induced Expression Of Vegf-c Bymentioning
confidence: 90%
“…In some experiments, keratinocytes were first treated for 24 h with a cell-permeable quinazoline compound (6-amino-4-(4-phenoxyphenylethylamino) quinazoline) (10 nM; Calbiochem) which inhibits NF-B transcriptional activation (18). Cells were then stimulated for an additional 24 h with combinations of IFN-␥ (R&D Systems), TNF-␣ (R&D Systems), IL-4 (R&D Systems), and IL-13 (R&D Systems).…”
Section: Keratinocyte Culturesmentioning
confidence: 99%